West Pharmaceutical Services, Inc. WST
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 38.96% | 10.95% | 5.07% | -5.64% | 6.22% |
| Total Depreciation and Amortization | -0.65% | 2.21% | -3.83% | 9.30% | 3.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -621.43% | 11.36% | 190.72% | -180.17% | 51.25% |
| Change in Net Operating Assets | 77.56% | 16.42% | -225.95% | 3,790.48% | 151.22% |
| Cash from Operations | 52.82% | 37.93% | -64.20% | 27.33% | 11.35% |
| Capital Expenditure | 9.49% | -1.17% | 43.89% | -20.22% | 15.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 282.64% | -1.17% | 43.89% | -20.22% | 15.82% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 99.01% | -16,700.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -26.14% | 17.33% | 63.04% | 15.00% | -23.08% |
| Repurchase of Common Stock | -48.25% | 47.78% | -149,950.00% | -100.00% | 80.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.27% | 0.63% | 0.00% | -4.64% | 0.00% |
| Other Financing Activities | 100.00% | -- | -- | -- | 100.00% |
| Cash from Financing | -46.72% | 46.61% | -2,538.46% | -1.74% | 22.82% |
| Foreign Exchange rate Adjustments | 206.25% | 80.95% | -1,580.00% | 86.11% | -119.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 133.06% | 68.28% | -265.79% | 37.04% | 12.61% |